South Tyneside and Sunderland NHS Foundation Trust
Sunderland, SR4 7TP, United Kingdom
NCT Number: NCT05850013
A prospective basic science study for collection of training and testing data for development of Lifelight® Junior
Looking for future studies?
Notify MeUp to 18 year
All sexes
Observational
Sunderland, SR4 7TP, United Kingdom
This study will be hospital-based, including paediatric emergency department (PED), inpatient wards and outpatient departments).
The participants will have their vital signs (such as heart rate, respiratory rate, oxygen saturation, blood pressure and temperature) measured using standard-of-care methods. Concurrent with this, videos of the participants' face/torso, and audio of the sounds made by the participants (cry, wheeze, cough) will be recorded. These data will later be used to train the Lifelight® Junior algorithms so that the technology can help in detection of illness and deterioration in children.
Primary Objective Collect the data needed to develop Lifelight® Junior so that it can measure the heart rate, respiratory rate and oxygen saturation of children.
Secondary Objective
To ensure the study collects data that can train Lifelight® Junior in an efficient way, the recruitment should be divided as follows:
Ideally, 15% of participants should have a Fitzpatrick skin tone of 4, 5 or 6 First reference to this - need to bring it in earlier and to reference it. However, this is not a hard target as achieving this figure is dependent on the demographic diversity of the study region.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lifelight® is an app developed by xim that measures VS including heart rate, respiratory rate and blood pressure. All you need to do to have these vital signs measured is look at your smartphone or tablet camera for 20-40 seconds. The app has used data from over 1 million heartbeats to learn how to measure these vital signs in adults. The technology is already available for doctors and nurses to use with adult patients in some specific scenarios
Time frame: 6 months
Train Lifelight algorithms across more extensive paediatric clinical ranges in 500 subjects
Time frame: 6 months
The following accuracy metrics are indicative minimum performance requirements for Lifelight® Junior. VISION-Junior should progress the technology towards these performance targets:
o Root mean square error of 5 bpm or lower
Time frame: 6 months
The following accuracy metrics are indicative minimum performance requirements for Lifelight® Junior. VISION-Junior should progress the technology towards these performance targets:
o Maximum error of 5 breaths per minute for 100% of the measurements
Time frame: 6 months
The following accuracy metrics are indicative minimum performance requirements for Lifelight® Junior. VISION-Junior should progress the technology towards these performance targets:
o Maximum error tolerance of 4%.
Xim Limited
Industry
The Measurement of Vital Signs in Children by Lifelight® Software in Comparison to the Standard of Care The VISION-Junior Study
Acronym: VISION-Jr
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04598659
Brain Diseases, Cardiovascular Diseases
Northampton, United Kingdom
View Trial DetailsNCT05319236
Cardiac Disease, Cardiovascular Abnormalities
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05780099
Cardiovascular Diseases, Chronic Disease
Milan, Italy
View Trial DetailsNCT06011356
Cardiovascular Diseases, Diabetes
London, United Kingdom (+44), United Kingdom
View Trial Details